Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid

Anti-laminin 332 mucous membrane pemphigoid (MMP) is an autoimmune blistering disease characterized by predominant mucosal lesions and autoantibodies against laminin 332. The exact diagnosis of anti-laminin 332 MMP is important since nearly 30% of patients develop solid cancers. This study compared...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Stephanie Goletz, Federica Giurdanella, Maike M. Holtsche, Miranda Nijenhuis, Barbara Horvath, Gilles F. H. Diercks, Detlef Zillikens, Takashi Hashimoto, Enno Schmidt, Hendri H. Pas
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/ababc5e370bd45299b68ae0f420b8693
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ababc5e370bd45299b68ae0f420b8693
record_format dspace
spelling oai:doaj.org-article:ababc5e370bd45299b68ae0f420b86932021-12-01T02:55:42ZComparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid1664-322410.3389/fimmu.2021.773720https://doaj.org/article/ababc5e370bd45299b68ae0f420b86932021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.773720/fullhttps://doaj.org/toc/1664-3224Anti-laminin 332 mucous membrane pemphigoid (MMP) is an autoimmune blistering disease characterized by predominant mucosal lesions and autoantibodies against laminin 332. The exact diagnosis of anti-laminin 332 MMP is important since nearly 30% of patients develop solid cancers. This study compared two independently developed diagnostic indirect immunofluorescence (IF) tests based on recombinant laminin 332 expressed in HEK239 cells (biochip mosaic assay) and the migration trails of cultured keratinocytes rich in laminin 332 (footprint assay). The sera of 54 anti-laminin 332 MMP, 35 non-anti-laminin 332 MMP, and 30 pemphigus vulgaris patients as well as 20 healthy blood donors were analyzed blindly and independently. Fifty-two of 54 and 54/54 anti-laminin 332 MMP sera were positive in the biochip mosaic and the footprint assay, respectively. In the 35 non-anti-laminin 332 MMP sera, 3 were positive in both tests and 4 others showed weak reactivity in the footprint assay. In conclusion, both assays are easy to perform, highly sensitive, and specific, which will further facilitate the diagnosis of anti-laminin 332 MMP.Stephanie GoletzFederica GiurdanellaMaike M. HoltscheMiranda NijenhuisBarbara HorvathGilles F. H. DiercksDetlef ZillikensTakashi HashimotoEnno SchmidtEnno SchmidtHendri H. PasFrontiers Media S.A.articleautoantibodyblisteringbiochipcancerfootprintlaminin 332Immunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic autoantibody
blistering
biochip
cancer
footprint
laminin 332
Immunologic diseases. Allergy
RC581-607
spellingShingle autoantibody
blistering
biochip
cancer
footprint
laminin 332
Immunologic diseases. Allergy
RC581-607
Stephanie Goletz
Federica Giurdanella
Maike M. Holtsche
Miranda Nijenhuis
Barbara Horvath
Gilles F. H. Diercks
Detlef Zillikens
Takashi Hashimoto
Enno Schmidt
Enno Schmidt
Hendri H. Pas
Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid
description Anti-laminin 332 mucous membrane pemphigoid (MMP) is an autoimmune blistering disease characterized by predominant mucosal lesions and autoantibodies against laminin 332. The exact diagnosis of anti-laminin 332 MMP is important since nearly 30% of patients develop solid cancers. This study compared two independently developed diagnostic indirect immunofluorescence (IF) tests based on recombinant laminin 332 expressed in HEK239 cells (biochip mosaic assay) and the migration trails of cultured keratinocytes rich in laminin 332 (footprint assay). The sera of 54 anti-laminin 332 MMP, 35 non-anti-laminin 332 MMP, and 30 pemphigus vulgaris patients as well as 20 healthy blood donors were analyzed blindly and independently. Fifty-two of 54 and 54/54 anti-laminin 332 MMP sera were positive in the biochip mosaic and the footprint assay, respectively. In the 35 non-anti-laminin 332 MMP sera, 3 were positive in both tests and 4 others showed weak reactivity in the footprint assay. In conclusion, both assays are easy to perform, highly sensitive, and specific, which will further facilitate the diagnosis of anti-laminin 332 MMP.
format article
author Stephanie Goletz
Federica Giurdanella
Maike M. Holtsche
Miranda Nijenhuis
Barbara Horvath
Gilles F. H. Diercks
Detlef Zillikens
Takashi Hashimoto
Enno Schmidt
Enno Schmidt
Hendri H. Pas
author_facet Stephanie Goletz
Federica Giurdanella
Maike M. Holtsche
Miranda Nijenhuis
Barbara Horvath
Gilles F. H. Diercks
Detlef Zillikens
Takashi Hashimoto
Enno Schmidt
Enno Schmidt
Hendri H. Pas
author_sort Stephanie Goletz
title Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid
title_short Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid
title_full Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid
title_fullStr Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid
title_full_unstemmed Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid
title_sort comparison of two diagnostic assays for anti-laminin 332 mucous membrane pemphigoid
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/ababc5e370bd45299b68ae0f420b8693
work_keys_str_mv AT stephaniegoletz comparisonoftwodiagnosticassaysforantilaminin332mucousmembranepemphigoid
AT federicagiurdanella comparisonoftwodiagnosticassaysforantilaminin332mucousmembranepemphigoid
AT maikemholtsche comparisonoftwodiagnosticassaysforantilaminin332mucousmembranepemphigoid
AT mirandanijenhuis comparisonoftwodiagnosticassaysforantilaminin332mucousmembranepemphigoid
AT barbarahorvath comparisonoftwodiagnosticassaysforantilaminin332mucousmembranepemphigoid
AT gillesfhdiercks comparisonoftwodiagnosticassaysforantilaminin332mucousmembranepemphigoid
AT detlefzillikens comparisonoftwodiagnosticassaysforantilaminin332mucousmembranepemphigoid
AT takashihashimoto comparisonoftwodiagnosticassaysforantilaminin332mucousmembranepemphigoid
AT ennoschmidt comparisonoftwodiagnosticassaysforantilaminin332mucousmembranepemphigoid
AT ennoschmidt comparisonoftwodiagnosticassaysforantilaminin332mucousmembranepemphigoid
AT hendrihpas comparisonoftwodiagnosticassaysforantilaminin332mucousmembranepemphigoid
_version_ 1718405921453899776